Patent · US Active

Tablet of sporoderm-removed ganoderma lucidum spore and preparation method thereof

US11931389B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 6, 2018
Grant dateMar 19, 2024
Priority date
Expiry dateApr 17, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2236/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a tablet of sporoderm-removed Ganoderma lucidum spore, which includes the following raw materials by weight parts: 13-20 parts of an aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, 3-5 parts of sorbitol, and 0.8-1.2 parts of povidone K30; A method for preparing the tablet of sporoderm-removed Ganoderma lucidum spore includes the following steps: mixing the aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, sorbitol and povidone K30 for 10-30 min, and subjecting the obtained mixture to granulating, screening and drying to obtain a granular material; and tableting the granular material to obtain the tablet of sporoderm-removed Ganoderma lucidum spore. The tablet of sporoderm-removed Ganoderma lucidum spore has a much higher content of active components, which are also easier to be absorbed. The tablet of sporoderm-removed Ganoderma lucidum spore is of effectively enhancing the body immunity and have anti-radiation and anti-tumor effects; and the dosage form of the tablet is convenient to carry and take.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.